Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Thompson, Shirley Patricia
Languages: English
Types: Unknown
The initial aims of this investigation were to develop a reliable assay system for measuring serum 1,Z5-dihydroxyvitamin D [1,Z5(OH)ZD] concentrations and to establish a normal range in young healthy adults. Compared with young healthy individuals, the elderly population are indeed vitamin D deficient. Vitamin D deficiency was also demonstrated in a group of elderly osteomalacic patients. Slight improvements in osteomalacia was achieved by one month of treatment with vitamin D3' or alphacalcidiol with or without calcium supplements. The improvements were small and occured slowly. A significant increase in the strength of bone seems unlikely to occur in the short term. On the present evidence the combination of alphacalcidiol and calcium supplements seems no better than vitamin D3 or alphacalcidiol alone although it may require closer monitoring to avoid hypercalcaemia. In a group of elderly patients with osteoporosis and femoral neck fracture (FNF), serum osteocalcin concentrations rose significantly in the first week after fracture fixation. The change in osteocalcin correlated well (p < 0.001) with the change in serum 1,Z5(OH)ZD concentration. Histomorphometric measurements of the extent of osteoid correlated better with osteocalcin than alkaline phosphatase. Serum concentrations of 1,Z5(OH)ZD were also reduced in elderly patients with FNF irrespective of the presence of osteomalacia and therefore cannot be used as a screening test for osteomalacia in this patient group. Reduction of 1,Z5(OH)ZD was not due to a reduction in vitamin D binding protein. It is suggested that the low rate of bone turnover in these elderly patients reduces the requirement of vitamin D. Of the ten elderly patients who had underwent laryngo pharyngeal surgery all developed hypocalcaemia. This immediate post-operative decrease, due to a rapid reduction in circulating PTH concentrations, lead to an overall increase in urinary calcium excretion. Serum concentration of 1,25(OH)2D also fell postoperatively thus potentiating the hypocalcaemic state in these patients. Thus, it is important to give parenteral feeding supplemented with calcium and vitamin D, preferably alphacalcidiol. If delayed then profound as well as prolonged hypocalcaemia can occur. The human osteosarcoma cell 20S metabolised 25(OH)D3 in a substrate concentration and time dependent manner to produce products which were secreted into the extracellular medium. These products eluted from HPLC with a retention time coincident with 24,25(OH)2D3 and exhibited an UV absorption spectrum characteristic of a vitamin D sterol. Mass spectroscopy analysis indicated at least two products were synthesised by the cells. One was identical to 24,25(OH)2D3; the other appeared to be an unsaturated trihydroxylated derivative of vitamin D3.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 2 Aaron JE, Gallagher JC, Anderson J, et 01. Frequency of osteomalacia and osteoporosis in frac~ tures of the proximal femur. Lancet 1974; i: 229-33. Wilton TJ, Hosking OJ, Pawley E, Stevens A, Harvey L. Osteomalacia and femoral neck fractures in the elderly patient. } Bone Joint Surg 1987; 69: 388-90.
    • 4 Wilton TJ, Hosking OJ, Pawley E, Stevens A, Harvey L. Screening for osteomalacia in eldeely patients with' femoral neck fracture. } Bone Joint Surg 1987; 69: 765-8.
    • 5 Campbell GA, Kemm JR, Hosking OJ, Boyd RV. How common is osteomalacia in the elderly? Lancet 1984; i: 386-8.
    • 6 Lian JB, Coutts M, Canalis E. Studies of hormonal regulation of osteocalcin synthesis in cultured fetal rat calvaria. } Bioi Chem 1985; 260: 8706-10.
    • 7 Silve C, Grosse B, Tay C, et 01. Response to parathyoid hormone and I· 25 dihydroxyvitamin 0, of bone derived cells isolated from normal children and children with abnormalities in skeletal development. } Clin Endocrinol Metab 1986; 62: 583-90.
    • 8 Price PA, Baukol SA. 1,25 dihydroxyvitamin 0, increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. } Bioi Chem 1980; 255: 11660-3.
    • 9 Skjodt H, Gallagher JA, Beresford IN, Couch M, Poser JW, Russell RGG. Vitamin 0 metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro. } Endocrinol 1985; 105: 391-6.
    • 10 Kemm JR, Campbell GA, Cotton RE, Hosking OJ. Osteoid in bones of eldeely patients without bone disease. Age Ageing 1984; 13: 144-51.
    • II Meunier PJ. Histomorphometry of the skeleton. In: Peck WA, ed. Bone and mineral research, vol I. Amsterdam: Excerpta Medica, 1983: 191-222.
    • 12 Editorial. Correcting the calcium. Br Med} 1977; i: 598.
    • 13 Fraher U, Adami S, Clemens TL, Jones G, O'Riordan JLH. Radioimmunoassay of 1·25 dihydroxyvitamin D2: studies on the metabolism of vitamin D2 in man. c/in Endocrinol 1983; 18: 151-65.
    • 14 Reinhardt TA, Horst RL, Orf JW, Hollis BW. A microassay for 1·25 dihydroxyvitamin 0 not requiring high performance liquid chromatography: application to clinical studies.} Clin Endocrinol Metab 1984; 58: 91-8.
    • 15 Buoillon R, Van Baelen H, De Moor P. The measurement of vitamin 0 binding protein in human serum. } Clm Endocrinol Metab 1977; 45: 225-31.
    • 16 Lips P, Bouillon R, Jongen MJM, Van Ginkel FC, Van Der Vijgh WJF, Netelenbos JS. The effect of trauma on serum concentrations of vitamin 0 metabolites in patients with hip fractures. Bone 1985; 6: 63-7.
    • 17 Ingle AR, Bailey JE, Matthews HL, Harrop JS. Performance and clinical utility of a commercially available 'C-terminal' PTH assay. Ann Clin Biochem 1986; 23: 434-9.
    • 18 Price PA. Parthemore JC, Deftos U. New biochemical marker for bone metabolism: measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with metabolic bone disease. } Clm Invest 1980; 66: 878- 83.
    • 19 Ismail F, Epstein S, Pacifici R, Droke 0, Thomas SB, Avioli LV. Serum bone GLA protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis. Calclf Tissue Int 1986; 39: 230-3.
    • 20 Brown JP, Delmas PO, Malaval L, Edouard C, Cbapuy MC, Meunier PJ. Serum bone GLAprotein: a specific marker for bone formation in post menopausal osteoporosis. Lancet 1984; i: 1091-3.
    • 21 Price PA, Williamson MK, Lothringer JW. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Bioi Chem 1981; 256: 12760-6.
    • 22 Lukert BP, Higgins JC, Stoskopf MM. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticosteroids.} Clin Endocrinol Metab 1986; 62: 1056-8.
    • 23 Delmas PO, Stennder 0, Wahner HW, Mann KG, Riggs BL. Increase in serum bone carboxyglutamic acid protein with ageing in women. Implications for the mechanism of age related bone loss. } Clm Invest 1983; 71: 1316-21.
    • 24 Price PA. Osteocalcin. In: Peck WA, ed., Bone and mineral research, "vol I. Amsterdam: Excerpta Medica, 1983; 157-90.
    • 25 Price PA, Nishimoto SK. Radioimmunoassay for the vitamin D-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci (USA) 1980; 77: 2234-7.
    • 26 Lian 18, Gunberg GM. Osteocalcin: biochemical considerations and clinical applications. Clin Orthop 1988; 226: 267-91.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article